Molecular mechanisms of immunosuppression and anti-inflammatory activities by glucocorticoids

American Journal of Respiratory and Critical Care Medicine

Volumn 154, Issue 2 SUPPL., 1996, Pages

  Didonato, Joseph A ^a   Saatcioglu, Fahri ^a   Karin, Michael ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; DRUG MECHANISM; DRUG RECEPTOR BINDING; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOREGULATION; MOLECULAR DYNAMICS; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; REVIEW; STEROID THERAPY; TRANSCRIPTION REGULATION;

EID: 0029737089     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm/154.2_pt_2.s11     Document Type: Review

References (35)

1. Parillo, J. E., and A. S. Fauci. 1979. Mechanisms of glucocorticoid action on immune process. Ann. Rev. Pharmacol. Toxicol. 19:179-209.
2. Cohen, J. J. 1989. In R. P. Scheimer, H. N. Claman, and A. L. Oronsky, editors. Anti-inflammatory Steroid Action. Basic and Clinical Aspects. Academic Press, San Diego. 111-131.
3. Werb, Z. 1989. Proteinases and matrix degradation. In W. N. Kelly, E. Harris, Jr., S. Ruddy, and C. B. Sledge, editors. Textbook of Rheumatology. W. B. Saunders, Philadelphia. 300-321.
4. Schleimer, R. P. 1993. An overview of glucocorticoid anti-inflammatory actions. Eur. J. Clin. Pharmacol. 45:3-7.
5. Saatcioglu, F., F.-X. Claret, and M. Karin. 1994. Negative transcriptional regulation by nuclear receptors. Semin. Cancer Biol. 5:347-359.
6. Akerblom, I. E., E. P. Slater, M. Beato, J. D. Baxter, and P. L. Mellon. 1988. Negative regulation by glucocorticoids through interference with cAMP responsive enhancer. Science 241:350-353.
7. Stauber, C., J. Altschimied, I. E. Akerblom, J. L. Marron, P. L. Mellon. 1992. Mutual cross-interference between glucocorticoid receptor and CREB inhibits transactivation in placetal cells. New Biologist 4:527-540.
8. Ray, A., and K. E. Prefontaine. 1994. Physical association and functional antagonism between the p65 subunit of transcription factor NFκB and the glucocorticoid receptor. Proc. Natl. Acacl. Sci. U.S.A. 91:752-756.
9. Auphan, N., J. A. DiDonato, A. Helmberg, C. Rosette, and M. Karin. 1995. Immunosuppression by glucocorticoids: Inhibition of NF-κB activity through induction of IκB synthesis. Science 270:286-290.
10. Mukaida, N., M. Morita, Y. Ishikawa, N. Rice, S. Okamoto, T. Kawahara, and K. Matsushima. 1994. Novel mechanism of glucocorticoidmediated gene repression : NF-κB is target for glucocorticoid-mediated interleukin-8 gene repression. J. Biol. Chem. 269:13289-13295.
11. Caldenhoven, E., J. Liden, S. Wissink, A. Van de Stolpe, J. Raaijmakers, L. Koenderman, S. Okret, J. Gustafsson, and P. T. Van der Saag. 1995. Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids. Mol. Endocrinol. 9:401-412.
12. Scheinman, R. I., A. Gualberto, C. M. Jewel, J. A. Cidlowski, and A. Baldwin, Jr. 1995. Characterization of mechanisms involved in transrepression of NF-κB by activated glucocorticoid receptors. Mol. Cell Biol. 15:943-953.
13. Scheinman, R. I., P. C. Cogswell, A. K. Lofquist, A. S. Baldwin, Jr. 1995. Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids. Science 270:283-286.
14. Angel, P., and M. Karin. 1991. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochem. Biophys. Acta 1072:129-157.
15. Grilli, M., J. J. Chiu, and M. J. Lenardo. 1993. NF-κB and Rel: participants in a multiform transcriptional regulatory system. Int. Rev. Cytol. 143:1-62.
16. Levine, M., and J. L. Manley. 1989. Transcriptional repression of eukaryotic promoters. Cell 59:405-408.
17. Weiland, S., U. Dobbeling, and S. Rusconi. 1991. Interference and synergism of glucocorticoid receptor and octamer factors. EMBO J. 10:2513-2521.
18. Lanigan, T. M., L. A. Tverberg, and A. F. Russo. 1993. Retinoic acid repression of cell-specific helix-loop-helix-octamer activation of the calcitonin/calcitonin gene-related peptide enhancer. Mol. Cell Biol. 13:6079-6088.
19. Johnson, P. F., and S. F. McKnight. 1989. Eukaryotic transcriptional regulatory proteins. Ann. Rev. Biochem. 58:799-839.
20. Angel, P., M. Imagawa, R. Chiu, B. Stein, R. J. Imbra, H. J. Rahmsdorf, C. Jonat, P. Herrlich, and M. Karin. 1987. Phorbol ester-inducible genes contain a common cis clement recognized by a TPA-modulated trans-acting factor. Cell 49:729-739.
21. Beato, M. 1989. Gene regulation by steroid hormones. Cell 56:335-344.
22. Frisch, S. M., and H. E. Ruley. 1987. Transcription from the stromelysin promoter is induced by interleukin-1 and repressed by dexamethasone. J. Biol. Chem. 262:3535-3542.
23. Offringa, R., A. M. Smis, A. Houling, J. L. Bos and A. J. van der Eb. 1988. Similar effect of adenovirus E1A and glucocorticoid hormones on the expression of the metalloproteinase stromelysin. Nucl. Acids Res. 16:10974-10983.
24. Brinkerhotf, C. E., I. M. Plucinska, L. A. Sheldon, and G. T. O'Connor. 1986. Half-life of synovial cell collagenase mRNA is modulated by phorbol myristate acetate but not by all trans-retinoic acid or dexamethasone. Biochemistry 25:6378-6384.
25. Yang-Yen, H. F., J. C. Chambard, Y. F. Sun, T. Smeal, T. J. Schmidt, J. Druin, and M. Karin. 1990. Transcriptional intererence between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 62:1205-1215.
26. Schule, R., P. Rangarajan, S. Kliewer, L. J. Ransone, N. Yang, I. M. Verma, and R. M. Evans. 1990. Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell 62:1217-1226.
27. Yang-Yen, H. F., X. F. Zhang, G. Graupner, M. Pfahl, and M. Karin. 1991. Antagonism between retinoic acid and AP-1: implications for tumor promotion and inflammation. New Biologist 3:1209-1219.
28. Konig, H., H. Ponta, H. J. Rahmsdorf, and P. Herrlich. 1992. Interference between pathway-specific transcription factors glucocorticoids antagonize phorbol ester-induced AP-1 activity without altering AP-1 site occupation in vivo. EMBO J. 11:2241-2246.
29. Baeuerle, P. A. 1991. The inducible transcriptional activator NF-κB: regulation by distinct protein subunits. Biochim. Biophys. Acta 1072: 63-80.
30. Haskill, S., A. A. Beg, S. M. Tompkins, J. S. Morris, A. D. Yurochko, A. Sampson-Johannes, R. Mondal, P. Ralph, and A. Baldwin, Jr. 1991. Characterization of an immediate-early gene induced in adherent monocytes that encodes IκB-like activity. Cell 65:1281-1289.
31. Finco, T. S., and A. S. Baldwin. 1995. Mechanistic aspects of NF-κB regulation: the emerging role of phosphorylation and proteolysis. Immunity 3:263-273.
32. Siebenlist, U., G. Franzoso, and K. Brown. 1994. Structure, regulation and function of NF-κB. Annu. Rev. Cell Biol. 10:405-455.
33. Miyamoto, S., M. J. Schmitt, and I. M. Verma. 1994. Qualitative changes in the subunit composition of kappa B-binding complexes during murine B-cell differentiation. Mol. Cell Biol. 11:5056-5060.
34. Henkel, T., T. Machleidt, I. Alkalay, M. Kronkem, Y. Ben-Neriah, and P. Baeuerle. 1993. Rapid proteolysis of IκBα is necessary for activation of transcription factor NF-κB. Nature 365:182-185.
35. Arenza-Seisdedos, F., J. Thomspon, M. S. Rodriguez, F. Bachelerie, D. Thomas, and R. Hay. 1995. Inducible nuclear expression of newly synthesized Iκbα negatively regulates DNA-binding and transcriptional activities of NF-κB. Mol. Cell Biol. 15:2689-2696.